Terui Y - Search Results

1

Rituximab maintenance improves outcomes of transformed diffuse large B-cell lymphoma: a retrospective study of 519 cases with de novo diffuse large B-cell lymphoma and 62 cases with concurrent diffuse large B-cell lymphoma and follicular lymphoma.

Uryu H, Mishima Y, Tsuyama N, Yokoyama M, Nishimura N, Fukuta T, Shirouchi Y, Okabe T, Inoue N, Takeuchi K, Terui Y. Uryu H, et al. Among authors: terui y. Leuk Lymphoma. 2021 Sep;62(9):2141-2150. doi: 10.1080/10428194.2021.1901091. Epub 2021 Mar 21. Leuk Lymphoma. 2021. PMID: 33749498

2

[Efficacy of CHOP+/-Rituximab-like therapy plus radiation therapy for patients with diffuse large B-cell lymphoma stage I].

Ueda K, Yokoyama M, Asai H, Koudaira M, Yamada S, Katsube A, Mishima Y, Sakajiri S, Takeuchi K, Saotome T, Terui Y, Takahashi S, Hatake K. Ueda K, et al. Among authors: terui y. Gan To Kagaku Ryoho. 2010 May;37(5):853-7. Gan To Kagaku Ryoho. 2010. PMID: 20495315 Japanese.

3

High thymidine kinase activity is a strong predictive factor for poor prognosis in peripheral T-cell lymphoma treated with cyclophosphamide, adriamycin, vincristine and prednisone.

Suzuki K, Terui Y, Nakano K, Nara E, Nasu K, Ueda K, Nishimura N, Mishima Y, Sakajiri S, Yokoyama M, Takahashi S, Hatake K. Suzuki K, et al. Among authors: terui y. Leuk Lymphoma. 2012 May;53(5):849-54. doi: 10.3109/10428194.2011.635858. Leuk Lymphoma. 2012. PMID: 22035416

4

Prognostic value of C-reactive protein, lactase dehydrogenase and anemia in recurrent or refractory aggressive lymphoma.

Suzuki K, Terui Y, Nishimura N, Mishima Y, Sakajiri S, Yokoyama M, Takahashi S, Tsuyama N, Takeuchi K, Hatake K. Suzuki K, et al. Among authors: terui y. Jpn J Clin Oncol. 2013 Jan;43(1):37-44. doi: 10.1093/jjco/hys194. Epub 2012 Nov 19. Jpn J Clin Oncol. 2013. PMID: 23166385

5

Non-gastric advanced mucosa-associated lymphoid tissue (MALT) lymphoma has worse prognosis than gastric MALT lymphoma even when treated with rituximab-containing chemotherapy.

Ueda K, Terui Y, Yokoyama M, Sakajiri S, Nishimura N, Tsuyama N, Takeuchi K, Hatake K. Ueda K, et al. Among authors: terui y. Leuk Lymphoma. 2013 Sep;54(9):1928-33. doi: 10.3109/10428194.2012.754023. Epub 2013 Jan 8. Leuk Lymphoma. 2013. PMID: 23216271

6

Prognostic value of high thymidine kinase activity in patients with previously untreated diffuse large B-cell lymphoma treated by rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone.

Suzuki K, Terui Y, Yokoyama M, Ueda K, Nishimura N, Mishima Y, Sakajiri S, Tsuyama N, Takeuchi K, Hatake K. Suzuki K, et al. Among authors: terui y. Leuk Lymphoma. 2013 Nov;54(11):2412-7. doi: 10.3109/10428194.2013.779690. Leuk Lymphoma. 2013. PMID: 23488601

7

Absolute peripheral monocyte count at diagnosis predicts central nervous system relapse in diffuse large B-cell lymphoma.

Nitta H, Terui Y, Yokoyama M, Mishima Y, Nishimura N, Ueda K, Kusano Y, Tsuyama N, Takeuchi K, Kanda Y, Hatake K. Nitta H, et al. Among authors: terui y. Haematologica. 2015 Jan;100(1):87-90. doi: 10.3324/haematol.2014.114934. Epub 2014 Sep 26. Haematologica. 2015. PMID: 25261092 Free PMC article.

8

Clinical and prognostic significance of aberrant T-cell marker expression in 225 cases of de novo diffuse large B-cell lymphoma and 276 cases of other B-cell lymphomas.

Tsuyama N, Ennishi D, Yokoyama M, Baba S, Asaka R, Mishima Y, Terui Y, Hatake K, Takeuchi K. Tsuyama N, et al. Among authors: terui y. Oncotarget. 2017 May 16;8(20):33487-33500. doi: 10.18632/oncotarget.16532. Oncotarget. 2017. PMID: 28380441 Free PMC article.

9

BCL2 expression in DLBCL: reappraisal of immunohistochemistry with new criteria for therapeutic biomarker evaluation.

Tsuyama N, Sakata S, Baba S, Mishima Y, Nishimura N, Ueda K, Yokoyama M, Terui Y, Hatake K, Kitagawa M, Ishizuka N, Tomita N, Takeuchi K. Tsuyama N, et al. Among authors: terui y. Blood. 2017 Jul 27;130(4):489-500. doi: 10.1182/blood-2016-12-759621. Epub 2017 May 18. Blood. 2017. PMID: 28522442 Free article. Clinical Trial.

10

[Efficacy of chemotherapy in extremely elderly patients with diffuse large B-cell lymphoma].

Takahashi A, Mishima Y, Yokoyama M, Inoue N, Kusano Y, Gunji T, Nitta H, Ueda K, Nishimura N, Tsuyama N, Takeuchi K, Terui Y, Hatake K. Takahashi A, et al. Among authors: terui y. Rinsho Ketsueki. 2017;58(5):427-432. doi: 10.11406/rinketsu.58.427. Rinsho Ketsueki. 2017. PMID: 28592754 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

317 results

Search Page

Filters